FDA staff takes no position on Moderna’s COVID booster

FDA staff takes no position on Moderna's COVID booster
FDA staff takes no position on Modernas COVID booster


Food and Drug Administration staffers didn’t take a firm stance on Moderna Inc.’s application for a booster dose, indicating there may not be sufficient data to support the extra dose. FDA staff, after reviewing a drugmaker’s application, often weigh whether it should be given a go-ahead. But they also didn’t take a position on Pfizer Inc.’s booster request, later granted. FDA staff reviews are part of the normal process before the agency makes a decision whether to clear a product.



Source link

Binance

Be the first to comment

Leave a Reply

Your email address will not be published.


*